| 1 |
|
At PCR, Drug-Eluting Stents From Asia, But At What Cost?
|
Cassak, D.
|
Channing, Weinberg & Co
|
2013
|
|
|
|
| 2 |
|
Cardionovum: As DEBs Heat Up, Who Needs The US Market?: Michael Orlowski proved with his first company that you can build a successful interventional cardiology company steering clear of the US. Can he do it again?
|
Cassak, D.
|
Channing, Weinberg & Co
|
2012
|
|
|
|
| 3 |
|
CircuLite: Treating Heart Failure's Lost Patients
|
Cassak, D.
|
Channing, Weinberg & Co.
|
2013
|
|
|
|
| 4 |
|
Cleveland Clinic Innovations: Creating A Global Innovation Engine
|
Cassak, D.
|
Channing, Weinberg & Co
|
2012
|
|
|
|
| 5 |
|
Covidien 2.0 - A Conversation With Joe Almeida: Joe Almeida inherited a company that was already performing well, and he is positioning it to continue its dynamic growth. Having run up an impressive track record over the past several years, where will - where can - Covidien go from here?
|
Cassak, D.
|
Channing, Weinberg & Co.
|
2013
|
|
|
|
| 6 |
|
Edwards' High Wire Act In TAVI: An Interview With Mike Mussallem
|
Cassak, D.
|
Channing, Weinberg & Co
|
2012
|
|
|
|
| 7 |
|
Eucomed - Finding Its Seat At The Table: An Interview With Guy Lebeau
|
Cassak, D.
|
Channing, Weinberg & Co
|
2012
|
|
|
|
| 8 |
|
InMedica: Slovenian Device Incubator Looks To Fill Infrastructure Gap
|
Cassak, D.
|
Channing, Weinberg & Co
|
2012
|
|
|
|
| 9 |
|
Innovation And Globalization In Medtech: An Interview With Medtronic's Omar Ishrak
|
Cassak, D.
|
Channing, Weinberg & Co
|
2012
|
|
|
|
| 10 |
|
J&J's New Path Forward - An Interview With Alex Gorsky: In his last interview before becoming CEO, Alex Gorsky talks (mostly) about the changes that Johnson & Johnson has made recently in its medical device business and discusses (briefly) his upcoming promotion to head of all of J&J
|
Cassak, D.
|
Channing, Weinberg & Co
|
2012
|
|
|
|
| 11 |
|
Mark Gelfand And Howard Levin The Folks Who Brought You Renal Denervation
|
Cassak, D.
|
Channing, Weinberg & Co.
|
2013
|
|
|
|
| 12 |
|
MD Start - Can Medtech Incubators Work In Europe?
|
Cassak, D.
|
Channing, Weinberg & Co
|
2012
|
|
|
|
| 13 |
|
Medtech Innovation From An Industrial Perspective: An Interview With GE Healthcare's John Dineen
|
Cassak, D.
|
Channing, Weinberg & Co
|
2013
|
|
|
|
| 14 |
|
Mitral Valve Pioneer: An Interview With Evalve's Ferolyn Powell And Fred St. Goar
|
Cassak, D.
|
Channing, Weinberg & Co
|
2013
|
|
|
|
| 15 |
|
Overcoming The Bias Against Medtech Entrepreneurship In Europe: An Interview With Martin Rothman: Why are European physicians so far ahead of the curve when it comes to innovative clinical practice, and so far behind when it comes to creating companies? Interventional cardiologist and serial entrepreneur Martin Rothman offers some answers
|
Cassak, D.
|
Channing, Weinberg & Co.
|
2013
|
|
|
|
| 16 |
|
SpineGuard: Taming Of The Screw
|
Cassak, D.
|
Channing, Weinberg & Co
|
2013
|
|
|
|
| 17 |
|
The CEO As R&D Chief - An Interview With Carl Zeiss' Michael Kaschke
|
Cassak, D.
|
Channing, Weinberg & Co
|
2012
|
|
|
|
| 18 |
|
The New Math Of Ortho Innovation: An Interview With Zimmer CEO David Dvorak After emerging from the DOJ settlements, the leading pure-play orthopedics company is emphasizing - and redefining - innovation to drive growth
|
Cassak, D.
|
Channing, Weinberg & Co
|
2013
|
|
|
|
| 19 |
|
The West Health Institute: Is This What The Future Of Health Care Looks Like?
|
Cassak, D.
|
Channing, Weinberg & Co
|
2013
|
|
|
|
| 20 |
|
Volcano: Learning To Thrive In A Declining PCI Market: Long used to a growing market driven by favorable demographics, cardiovascular companies are facing a declining PCI market, in the US and Europe at least, and are being forced to shift their strategies to adapt. Volcano, for one, is articulating a new way to approach this declining market
|
Cassak, D.
|
Channing, Weinberg & Co.
|
2013
|
|
|
|
